Literature DB >> 17680993

The role of the VQIVYK peptide in tau protein phosphorylation.

Mar Perez1, Ismael Santa-María, Elena Tortosa, Raquel Cuadros, Mercedes Del Valle, Felix Hernández, Francisco J Moreno, Jesús Avila.   

Abstract

Although it remains unclear whether they are related to one another, tau aggregation and phosphorylation are the main pathological hallmarks of the neuronal disorders known as tauopathies. The capacity to aggregate is impaired in a variant of the tau 3R isoform that lacks residues 306-311 (nomenclature for the largest CNS tau isoform) and hence, we have taken advantage of this feature to study how phosphorylation and aggregation may be related as well as the role of this six amino acid peptide (VQIVYK). Through these analyses, we found that the phosphorylation of the tau variant was higher than that of the complete tau protein and that not only the deletion of these residues, but also the interaction of these residues, in tau 3R, with thioflavin-S augmented tau phosphorylation by glycogen synthase kinase 3. In addition, the binding of the peptide containing the residues 306-311 to the whole tau protein provoked an increase in tau phosphorylation. This observation could be physiologically relevant as may suggest that tau-tau interactions, through those residues, facilitate tau phosphorylation. In summary, our data indicate that deletion of residues VQIVYK, in tau protein produces an increase in tau phosphorylation, without tau aggregation, because the VQIVYK peptide, that favors aggregation, is missing. On the other hand, when the whole tau protein interacts with thioflavin-S or the peptide VQIVYK, an increase in both aggregation and phosphorylation occurs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17680993     DOI: 10.1111/j.1471-4159.2007.04834.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  6 in total

1.  NAP alpha-aminoisobutyric acid (IsoNAP).

Authors:  Illana Gozes; Yulie Schirer; Anat Idan-Feldman; Merav David; Sharon Furman-Assaf
Journal:  J Mol Neurosci       Date:  2014-01       Impact factor: 3.444

2.  The importance of hydrogen bonding between the glutamine side chains to the formation of amyloid VQIVYK parallel beta-sheets: an ONIOM DFT/AM1 study.

Authors:  Joshua A Plumley; J J Dannenberg
Journal:  J Am Chem Soc       Date:  2010-02-17       Impact factor: 15.419

3.  A droplet reactor on a super-hydrophobic surface allows control and characterization of amyloid fibril growth.

Authors:  Peng Zhang; Manola Moretti; Marco Allione; Yuansi Tian; Javier Ordonez-Loza; Davide Altamura; Cinzia Giannini; Bruno Torre; Gobind Das; Erqiang Li; Sigurdur T Thoroddsen; S Mani Sarathy; Ida Autiero; Andrea Giugni; Francesco Gentile; Natalia Malara; Monica Marini; Enzo Di Fabrizio
Journal:  Commun Biol       Date:  2020-08-20

4.  Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6.

Authors:  Abha Dangi; Abhishek Ankur Balmik; Archana Kisan Ghorpade; Nalini Vijay Gorantla; Shweta Kishor Sonawane; Subashchandrabose Chinnathambi; Udaya Kiran Marelli
Journal:  RSC Adv       Date:  2020-07-21       Impact factor: 4.036

5.  Epitope alteration by small molecules and applications in drug discovery.

Authors:  Biyue Zhu; Jing Yang; Richard Van; Fan Yang; Yue Yu; Astra Yu; Kathleen Ran; Keyi Yin; Yingxia Liang; Xunuo Shen; Wei Yin; Se Hoon Choi; Ying Lu; Changning Wang; Yihan Shao; Liang Shi; Rudolph E Tanzi; Can Zhang; Yan Cheng; Zhirong Zhang; Chongzhao Ran
Journal:  Chem Sci       Date:  2022-06-28       Impact factor: 9.969

6.  Stabilization of Microtubule-Unbound Tau via Tau Phosphorylation at Ser262/356 by Par-1/MARK Contributes to Augmentation of AD-Related Phosphorylation and Aβ42-Induced Tau Toxicity.

Authors:  Kanae Ando; Akiko Maruko-Otake; Yosuke Ohtake; Motoki Hayashishita; Michiko Sekiya; Koichi M Iijima
Journal:  PLoS Genet       Date:  2016-03-29       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.